+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neuropathic Pain Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

  • ID: 5136527
  • Report
  • June 2020
  • Region: Global
  • 238 pages
  • Transparency Market Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • MORE
Neuropathic Pain Therapeutics Market - Scope of the Report

This report on the global neuropathic pain therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global neuropathic pain therapeutics market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neuropathic pain therapeutics market from 2020 to 2030.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global neuropathic pain therapeutics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global neuropathic pain therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global neuropathic pain therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neuropathic pain therapeutics market.

The report also delves into the competition landscape of the global neuropathic pain therapeutics market. Key players operating in the global neuropathic pain therapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global neuropathic pain therapeutics market that have been profiled in this report.

Key Questions Answered in Neuropathic Pain Therapeutics Market Report
  • What is the sales/revenue generated by neuropathic pain drugs across all regions during the forecast period?
  • What are the opportunities in the global neuropathic therapeutics pain market?
  • What are the major drivers, restraints, opportunities, and threats in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which indication segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Neuropathic Pain Therapeutics Market - Research Objectives and Research Approach

The comprehensive report on the global neuropathic pain therapeutics market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global neuropathic pain therapeutics market in terms of drug class, disease type, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global neuropathic pain therapeutics market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • AstraZeneca
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • MORE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Neuropathic Pain Therapeutics Market

4. Market Overview
4.1. Introduction & Overview
4.2. Product Overview
4.3. Market Dynamics
4.4. Global Neuropathic Pain Therapeutics Market Analysis and Forecast, 2018-2030

5. Market Outlook
5.1. Pipeline Analysis
5.2. Treatment Guidelines
5.3. COVID-19 Pandemics Impact on Industry

6. Global Neuropathic Pain Therapeutics Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Global Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
6.3. Global Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Drug Class

7. Global Neuropathic Pain Therapeutics Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Global Neuropathic Pain Therapeutics Market Value (US$) Forecast, by Indication, 2018-2030
7.3. Global Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Indication

8. Global Neuropathic Pain Therapeutics Market Analysis and Forecast, by Route of Administration
8.1. Introduction & Definition
8.2. Global Neuropathic Pain Therapeutics Market Value (US$) Forecast, by Route of Administration, 2018-2030
8.3. Global Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Route of Administration

9. Global Neuropathic Pain Therapeutics Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Global Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
9.3. Global Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Distribution Channel

10. Global Neuropathic Pain Therapeutics Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Region
10.3. Global Neuropathic Pain Therapeutics Market Attractiveness Analysis, by Region

11. North America Neuropathic Pain Therapeutics Market Analysis and Forecast
11.1. Introduction
11.2. North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
11.3. North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
11.4. North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
11.5. North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
11.6. North America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
11.7. North America Neuropathic Pain Therapeutics Market Attractiveness Analysis

12. Europe Neuropathic Pain Therapeutics Market Analysis and Forecast
12.1. Introduction
12.2. Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
12.3. Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
12.4. Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
12.5. Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
12.6. Europe Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
12.7. Europe Neuropathic Pain Therapeutics Market Attractiveness Analysis

13. Asia Pacific Neuropathic Pain Therapeutics Market Analysis and Forecast
13.1. Introduction
13.2. Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
13.3. Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
13.4. Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
13.5. Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
13.6. Asia Pacific Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
13.7. Asia Pacific Neuropathic Pain Therapeutics Market Attractiveness Analysis

14. Latin America Neuropathic Pain Therapeutics Market Analysis and Forecast
14.1. Introduction
14.2. Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
14.3. Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
14.4. Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
14.5. Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
14.6. Latin America Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
14.7. Latin America Neuropathic Pain Therapeutics Market Attractiveness Analysis

15. Middle East & Africa Neuropathic Pain Therapeutics Market Analysis and Forecast
15.1. Introduction
15.2. Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
15.3. Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2018-2030
15.4. Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
15.5. Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
15.6. Middle East & Africa Neuropathic Pain Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
15.7. Middle East & Africa Neuropathic Pain Therapeutics Market Attractiveness Analysis

16. Competition Landscape
16.1. Competition Matrix
16.2. Market Share Analysis, by Company, 2019
16.3. Company Profiles
Note: Product cover images may vary from those shown
3 of 3
  • Novartis AG
  • GlaxoSmithKline plc
  • AstraZeneca
  • Pfizer, Inc.
  • Eli Lilly and Company
  • Mallinckrodt Pharmaceuticals
  • Johnson & Johnson
  • Abbott
  • Endo Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Limited
  • Merck & Co., Inc.
Note: Product cover images may vary from those shown
Adroll
adroll